In some patients, however—particularly those experiencing GI symptoms of PASC—populations of cytotoxic CD4+ and CD8+ T-cells continue to evolve into new clones, suggesting a role for T-cell-mediated inflammation in PASC (285). The gene discussed is CD8A; the disease is long COVID-19.